Abstract: A method is for operating an x-ray device for recording a series of images, in particular for fluoroscopic monitoring of a recording region of a patient. The method includes acquiring fluoroscopy images of a patient with a recording rate and a recording dose; and displaying the fluoroscopy images acquired to a user on a display device at a frame rate. The recording dose is selected automatically as a function of a change in image contents between consecutive fluoroscopy images acquired.

Abstract: A detection device serves for detecting a structure on an area portion of a lithography mask. The detection device has a first spatially resolving detector and also a further spatially resolving detector arranged separately therefrom. The first spatially resolving detector is embodied as a high-intensity (HI) detector and is arranged in an HI beam path of the detection light which emanates from the mask area portion. The further spatially resolving detector is embodied as a low-intensity (LI) detector and is arranged in an LI beam path of the detection light. The HI beam path on the one hand and the LI beam path on the other hand are embodied such that the HI detector is illuminated with a detection light intensity that is at least twice the magnitude of the detection light intensity with which the LI detector is illuminated. The two spatially resolving detectors are embodied for simultaneously detecting the detection light.

Abstract: The present disclosure is drawn to a method of treating a patient in need of treatment, comprising identifying a patient in need of treatment for stroke, traumatic brain injury, spinal cord injury, myocardial infarction, shock, organ ischemia, ventricular arrhythmias, ischemic injury, or hypoxia/ischemia; administering a bolus of glyburide to the patient; and administering a continuous infusion of glyburide to the patient at from about 15 ?g/hr and about 300 ?g/hr, wherein the continuous infusion glyburide is administered for a period of time more than about 20 hours.

Abstract: NSC antagonists are disclosed as useful in the treatment of dementia, in delaying the onset of dementia, and in the prevention of dementia. Dementia so treated may be, for example, Alzheimer's Disease (AD). NSC antagonists for treating dementia such as AD may be administered alone, a) in combination with other drugs used for treating dementia, b) in combination with drugs that stabilize or increase blood plasma glucose levels, or with both a) and b). Pharmaceutical compositions, dosage forms, and methods for using the same are disclosed, which include NSC antagonists, NSC antagonists combined with dementia drugs, NSC antagonists combined with glucose-level stabilizing or enhancing drugs, or combinations of these. Dosage forms may be designed to provide stable plasma levels for extended periods of time.

Abstract: At least one example embodiment provides a method for automatic positioning of an X-ray source of a medical X-ray system with a mobile X-ray detector. The method includes determining an examination region of the examination object, acquiring a position and a location of the examination object and the examination region by way of an optical position determining system, localizing the examination region, ascertaining a field point of the central ray of the X-ray source and a collimator size of the X-ray source based on the localized examination region, and automatic positioning of the X-ray source based on the field point and the collimator size.

Abstract: The invention relates to a device and a method for characterizing a microlithographic mask. A device according to the invention has an illumination optical unit for illuminating structures of a mask intended for use in a lithography process in a microlithographic projection exposure apparatus, a detector unit, and an evaluation unit for evaluating the data recorded by the detector unit, wherein the detector unit is configured for the spatially resolved determination of both the intensity and the polarization state of the respectively impinging light emanating from the mask.

Abstract: The present invention provides compositions, methods for lyophilizing compounds and making pharmaceutical compositions, and kits providing solutions and lyophilized formulations of compounds. The compositions, methods, and kits are particularly useful in pharmaceutical applications involving therapeutic agents that have low solubility at low and medium pH values. Certain embodiments provide methods for lyophilizing compounds in liquid solutions, which include the steps of: a) preparing aqueous solutions of a compound of interest in the absence of buffer; b) adjusting the pH to high values of pH in order to increase the solubility of the compound of interest; and c) freeze-drying the solution to provide a lyophilized solid composition. Aqueous solutions including buffer are also disclosed. Lyophilized formulations, including micronized and non-micronized powders, are provided.

Abstract: A method is for collimator element adjustment of an x-ray system with a central x-ray axis and an optical axis of an optical imaging device differing therefrom. In an embodiment, the method includes displaying a first recorded optical image of the examination object; marking a target region as a region to be shown in the displayed first recorded optical image; determination of at least one first collimator element position value based on the marked target region in the first recorded optical image; and adjustment of the collimator element position with the at least one first collimator element position value determined.

Abstract: The present disclosure is drawn to a method of treating a patient in need of treatment, comprising identifying a patient in need of treatment for stroke, traumatic brain injury, spinal cord injury, myocardial infarction, shock, organ ischemia, ventricular arrhythmias, ischemic injury, or hypoxia/ischemia; administering a bolus of glyburide to the patient; and administering a continuous infusion of glyburide to the patient at from about 15 ?g/hr and about 300 ?g/hr, wherein the continuous infusion glyburide is administered for a period of time more than about 20 hours.

Abstract: NSC antagonists are disclosed as useful in the treatment of dementia, in delaying the onset of dementia, and in the prevention of dementia. Dementia so treated may be, for example, Alzheimer's Disease (AD). NSC antagonists for treating dementia such as AD may be administered alone, a) in combination with other drugs used for treating dementia, b) in combination with drugs that stabilize or increase blood plasma glucose levels, or with both a) and b). Pharmaceutical compositions, dosage forms, and methods for using the same are disclosed, which include NSC antagonists, NSC antagonists combined with dementia drugs, NSC antagonists combined with glucose-level stabilizing or enhancing drugs, or combinations of these. Dosage forms may be designed to provide stable plasma levels for extended periods of time.

Abstract: A detection device serves for detecting a structure on an area portion of a lithography mask. The detection device has a first spatially resolving detector and also a further spatially resolving detector arranged separately therefrom. The first spatially resolving detector is embodied as a high-intensity (HI) detector and is arranged in an HI beam path of the detection light which emanates from the mask area portion. The further spatially resolving detector is embodied as a low-intensity (LI) detector and is arranged in an LI beam path of the detection light. The HI beam path on the one hand and the LI beam path on the other hand are embodied such that the HI detector is illuminated with a detection light intensity that is at least twice the magnitude of the detection light intensity with which the LI detector is illuminated. The two spatially resolving detectors are embodied for simultaneously detecting the detection light.

Abstract: The present invention provides methods for treating and preventing viral disease in farmed fish. In particular, the present invention relates to compositions and methods for improving heart health in farmed salmon.

Abstract: The present invention provides compositions, methods for lyophilizing compounds and making pharmaceutical compositions, and kits providing solutions and lyophilized formulations of compounds. The compositions, methods, and kits are particularly useful in pharmaceutical applications involving therapeutic agents that have low solubility at low and medium pH values. Certain embodiments provide methods for lyophilizing compounds in liquid solutions, which include the steps of: a) preparing aqueous solutions of a compound of interest in the absence of buffer; b) adjusting the pH to high values of pH in order to increase the solubility of the compound of interest; and c) freeze-drying the solution to provide a lyophilized solid composition. Aqueous solutions including buffer are also disclosed. Lyophilized formulations, including micronized and non-micronized powders, are provided.

Abstract: NSC antagonists are disclosed as useful in the treatment of dementia, in delaying the onset of dementia, and in the prevention of dementia. Dementia so treated may be, for example, Alzheimer's Disease (AD). NSC antagonists for treating dementia such as AD may be administered alone, a) in combination with other drugs used for treating dementia, b) in combination with drugs that stabilize or increase blood plasma glucose levels, or with both a) and b). Pharmaceutical compositions, dosage forms, and methods for using the same are disclosed, which include NSC antagonists, NSC antagonists combined with dementia drugs, NSC antagonists combined with glucose-level stabilizing or enhancing drugs, or combinations of these. Dosage forms may be designed to provide stable plasma levels for extended periods of time.

Abstract: A method is for operating an x-ray device for recording a series of images, in particular for fluoroscopic monitoring of a recording region of a patient. The method includes acquiring fluoroscopy images of a patient with a recording rate and a recording dose; and displaying the fluoroscopy images acquired to a user on a display device at a frame rate. The recording dose is selected automatically as a function of a change in image contents between consecutive fluoroscopy images acquired.

Abstract: A power tool, includes an electrical motor unit connectable to a battery unit, wherein: a step-up converter, connectable between the battery unit and electrical motor unit, converts a battery voltage Ubattery provided by the battery unit to a higher step-up voltage Ustep-up, and provides Ustep-up to the electrical motor unit as an output voltage Uoutput; a bypass circuit, arranged in parallel with the step-up converter, connects the battery unit to and provides Ubattery to the electrical motor unit as Uoutput; and at least one control unit is arranged to control the step-up converter and the bypass circuit, such that Uoutput can switch between Ubattery and Ustep-up, based on tool related parameters, including Uoutput, an output current Ioutput provided to the motor, a rotational speed ?motor of the motor unit multiplied with a torque T provided by the tool, and an output power Poutput provided to the electrical motor unit.

Abstract: The present disclosure is drawn to a method of treating a patient in need of treatment, comprising identifying a patient in need of treatment for stroke, traumatic brain injury, spinal cord injury, myocardial infarction, shock, organ ischemia, ventricular arrhythmias, ischemic injury, or hypoxia/ischemia; administering a bolus of glyburide to the patient; and administering a continuous infusion of glyburide to the patient at from about 15 ?g/hr and about 300 ?g/hr, wherein the continuous infusion glyburide is administered for a period of time more than about 20 hours.

Abstract: NSC antagonists are disclosed as useful in the treatment of dementia, in delaying the onset of dementia, and in the prevention of dementia. Dementia so treated may be, for example, Alzheimer's Disease (AD). NSC antagonists for treating dementia such as AD may be administered alone, a) in combination with other drugs used for treating dementia, b) in combination with drugs that stabilize or increase blood plasma glucose levels, or with both a) and b). Pharmaceutical compositions, dosage forms, and methods for using the same are disclosed, which include NSC antagonists, NSC antagonists combined with dementia drugs, NSC antagonists combined with glucose-level stabilizing or enhancing drugs, or combinations of these. Dosage forms may be designed to provide stable plasma levels for extended periods of time.

Abstract: The present invention provides compositions, methods for lyophilizing compounds and making pharmaceutical compositions, and kits providing solutions and lyophilized formulations of compounds. The compositions, methods, and kits are particularly useful in pharmaceutical applications involving therapeutic agents that have low solubility at low pH and medium pH values. Certain embodiments provide methods for lyophilizing compounds in liquid solutions, which include the steps of: a) preparing aqueous solutions of a compound of interest in the absence of buffer; b) adjusting the pH to high values of pH in order to increase the solubility of the compound of interest; and c) freeze-drying the solution to provide a lyophilized solid composition. Aqueous solutions including buffer are also disclosed. Lyophilized formulations, including micronized and non-micronized powders, are provided.

Abstract: The present disclosure is drawn to a method of treating a patient in need of treatment, comprising identifying a patient in need of treatment for stroke, traumatic brain injury, spinal cord injury, myocardial infarction, shock, organ ischemia, ventricular arrhythmias, ischemic injury, or hypoxia/ischemia; administering a bolus of glyburide to the patient; and administering a continuous infusion of glyburide to the patient at from about 15 ?g/hr and about 300 ?g/hr, wherein the continuous infusion glyburide is administered for a period of time more than about 20 hours.